跳至主要内容
临床试验/CTRI/2022/08/044804
CTRI/2022/08/044804尚未招募未知

Multicentre trial to assess theperformance of centralized assaysolutions for detection of MTB and resistance to Rifampin and Isoniazid

Foundation for Innovative New Diagnostics India0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Aged Equal ore more than 18 years.
  • 2) Clinical suspicion of pulmonary TB including productive cough of equal or more than 2 weeks and equal or more than 1 week for other symptom typical of pulmonary TB listed below:
  • 2.1. Fever
  • 2.2. Contact with active case
  • 2.3. Malaise
  • 2.4. Haemoptysis
  • 2.5. Recent weight Loss
  • 2.6. Chest Pain
  • 2.7. Night sweats
  • 2.8. Loss of appetite
  • 3) Willing to Provide two sputum specimens at enrollment
  • 4) Willing to provide informed consent.

排除标准

  • 1) Only extra-pulmonary TB signs & symptoms
  • 2) Receipt of any dose of TB treatment within 6 months prior to enrolment or currently on TB treatment

研究者

相似试验